NCT05739708

Brief Summary

Like any chronic disease, asthma exposes individuals to stressful and threatening situations that require ongoing cognitive, emotional, behavioral and social adaptation. Approximately 5-10% of patients with asthma have a treatment-resistant disease, with frequent emergency room visits and hospitalizations. These patients are responsible for the majority of the overall asthma-related disease burden and also represent more than half of the total direct costs of asthma management. The scientific literature shows that personality traits, attachment type and psychological disorders will significantly influence disease coping strategies, disease experience, quality of life, adherence and therapeutic alliance. Although some data exist in asthma, there are currently no studies that have evaluated the overall psychological profile of asthma patients, and we have no data specifically on the population of severe asthmatics, who are the most difficult to manage. A better understanding of the overall psychological dimension of asthma patients will make it possible to offer therapeutic education programs that are more targeted according to the psychosocial skills of the patient and finally improve the overall management of the disease.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for not_applicable asthma

Timeline
Completed

Started Feb 2023

Shorter than P25 for not_applicable asthma

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2023

Completed
13 days until next milestone

Study Start

First participant enrolled

February 15, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 22, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2024

Completed
Last Updated

February 23, 2024

Status Verified

February 1, 2024

Enrollment Period

1 year

First QC Date

February 2, 2023

Last Update Submit

February 22, 2024

Conditions

Outcome Measures

Primary Outcomes (7)

  • Description of the psychological profile of severe asthma patients

    Score on questionnaires assessing coping strategies (ACL-F)

    1 day

  • Description of the psychological profile of severe asthma patients

    Score on questionnaire personality traits (BFI-Fr)

    1 day

  • Description of the psychological profile of severe asthma patients

    Score on questionnaire attachment types (RSQ)

    1 day

  • Description of the psychological profile of severe asthma patients

    Score on questionnaire anxiety and depression (HADS)

    1 day

  • Description of the psychological profile of severe asthma patients

    Score on questionnaire quality of life (AQLQ)

    1 day

  • Description of the psychological profile of severe asthma patients

    Score on questionnaire patient-physician therapeutic alliance (WAI-SR)

    1 day

  • Description of the psychological profile of severe asthma patients

    Score on questionnaire 0Asthma Control Test (ACT)

    1 day

Study Arms (1)

Asthma patients

OTHER
Other: Questionnaires

Interventions

The time to complete the different questionnaires is estimated to be 60 minutes.

Also known as: Asthma Coping List (French version), Big Five Inventory (French version), Relationship Scales Questionnaire (French version), Hospital Anxiety and Depression Scale (French version), Asthma Quality of Life Questionnaire (French version), Working Alliance Inventory-Short Form Revised (French version), Asthma Control Test (French version), Morisky Medication Adherence Scale (French version)
Asthma patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient aged ≥ 18 years and followed in the Respiratory Department of the Besançon University Hospital for an asthmatic disease diagnosed for more than 12 months. Will be considered as severe patients, asthma patients with uncontrolled asthma despite high therapeutic pressure (GINA levels 4 and 5) and patients requiring to be controlled high doses of inhaled corticosteroids and long-acting beta-2-agonists (or anti-leukotriene/theophylline) in the past year or systemic corticosteroid therapy (\>50% in the previous year) (ATS-ERS 2014 criteria).
  • Patient able to understand the objectives of the research
  • Patient who has signed a research consent form
  • Patient affiliated to a French social security system or beneficiary of such a system

You may not qualify if:

  • Patient with reading and comprehension difficulties that prevent them from completing the questionnaires
  • Motor disability that prevents the patient from completing the questionnaires
  • Legal incapacity or limited legal capacity
  • Subject unlikely to cooperate with the study and/or poor cooperation anticipated by the the investigator
  • Subject without health insurance
  • Subject under court protection, guardianship, conservatorship, or protective supervision. protection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Besançon - Service de Pneumologie

Besançon, Doubs, 25000, France

RECRUITING

MeSH Terms

Conditions

Asthma

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Lucie Laurent, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2023

First Posted

February 22, 2023

Study Start

February 15, 2023

Primary Completion

February 15, 2024

Study Completion

February 15, 2024

Last Updated

February 23, 2024

Record last verified: 2024-02

Locations